U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606820) titled 'Real-World Study of Cligabalin for the Treatment of Neurogenic Rosacea' on May 19.
Brief Summary: A Real-World Study of Cligabalin(HSK16149) for the Treatment of Neurogenic Rosacea
Study Start Date: May 20
Study Type: INTERVENTIONAL
Condition:
Rosacea
Intervention:
DRUG: HSK16149 20mg BID
different dose
DRUG: HSK16149 20mg qd
different dose
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Published by HT Digital Content Services with permission from Health Daily Digest....